The pharmacovigilance and drug safety software market size was valued at USD 225.36 million in 2025 and is projected to grow from USD 40.91 million in 2026 to USD 421.99 million by 2034 at a CAGR of 7 ...
In late September 2023, the U.S. Food and Drug Administration (FDA) released a draft guidance on “Regulatory Considerations for Prescription Drug Use-Related Software.” This guidance expands on (and ...
FDA’s recent draft guidance, Regulatory Considerations for Prescription Drug Use Related Software, proposes a regulatory framework for software disseminated by a drug sponsor that supplements or ...
NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, announced the launch of Software-Enhanced Drug™ therapies, part of ...
The global drug discovery software market is emerging as a high-impact segment within the life sciences technology ecosystem, driven by the urgent need for faster, more cost-effective, and data-driven ...
The US Food and Drug Administration (FDA) issued a request for comment on Monday that sets forth a proposal for a new framework on the regulation of software applications for use with one or more ...
The US Food and Drug Administration (FDA) has released draft guidance with considerations on how to include software outputs of drug use-related software in prescription labeling. In the draft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results